These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35778354)

  • 1. IgA nephropathy with acute kidney disease: Characteristics, prognosis, and causes.
    Wang X; Guo Z; Huang B; Xie M; Ren J; Zhu Y; Guo H; Wang Y; Yu D; Zhang J; Zhang L
    Eur J Intern Med; 2022 Nov; 105():46-53. PubMed ID: 35778354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
    Chen MG; Ye XH; Liang HY; Yang Q
    Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
    Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M; Li W; Zou G; Zhang C; Fang J
    Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
    J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents.
    Ruan Y; Hong F; Wu J; Lin M; Wang C; Lian F; Cao F; Yang G; Huang L; Huang Q
    J Nephrol; 2022 May; 35(4):1113-1121. PubMed ID: 35290652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy.
    Shen Y; Xiao T; Yu Z; Huang Y; He T; Li H; Zhang J; Xiong J; Zhao J
    Ren Fail; 2022 Dec; 44(1):994-1003. PubMed ID: 35658824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
    Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
    Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury.
    Zhang L; Li J; Yang S; Huang N; Zhou Q; Yang Q; Yu X
    Ren Fail; 2016 Jun; 38(5):799-805. PubMed ID: 27050722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
    J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis.
    Sevillano ÁM; Cabrera J; Gutiérrez E; Morales E; Mérida E; Huerta A; Cavero T; Hernández E; Moreno JA; Praga M
    Nefrologia; 2015; 35(1):42-9. PubMed ID: 25611832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crescentic IgA nephropathy in children.
    Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of IgA nephropathy combined with other glomerular diseases.
    Jiang L; Dong B; Yan Y; Zheng S; Hu Y; Zuo L; Shi H
    Medicine (Baltimore); 2019 Oct; 98(41):e17388. PubMed ID: 31593089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposed Oxford classification-based clinicopathological nomogram for predicting short-term renal outcomes in IgA nephropathy after acute kidney injury.
    Zhang L; Zhuang X; Liao X
    Eur J Intern Med; 2018 Jun; 52():60-66. PubMed ID: 29395936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal survival and risk factors in IgA nephropathy with crescents.
    Ma F; Liu L; Dong R; Yang X; Wei L; Li L; Bai M; Sun S
    Int Urol Nephrol; 2020 Aug; 52(8):1507-1516. PubMed ID: 32533530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
    Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.